[Translation] A multicenter, double-blind, randomized, controlled clinical trial to evaluate the equivalence and safety of 5% minoxidil foam and ROGAINE® (5% minoxidil foam) in adult male subjects with androgenetic alopecia

主要试验目的：评估成年雄激素性脱发（AGA）男性受试者使用5%米诺地尔泡沫剂与使用 ROGAINE®（5%米诺地尔泡沫剂）治疗的临床疗效等效性。次要试验目的：比较试验药物和对照药物在成年雄激素性脱发男性受试者中的安全性。

[Translation]

Primary study objective: To evaluate the clinical efficacy equivalence of 5% minoxidil foam and ROGAINE® (5% minoxidil foam) in adult male subjects with androgenetic alopecia (AGA). Secondary study objective: To compare the safety of the test drug and the control drug in adult male subjects with androgenetic alopecia.

Start Date27 Dec 2024

Sponsor / Collaborator

Shanxi Ante Bio-Pharmaceutical Co., Ltd.

CTR20230642

/ CompletedNot Applicable

空腹及餐后口服恩扎卢胺软胶囊在中国成年健康志愿者中的人体生物等效性研究

[Translation] Study on the bioequivalence of enzalutamide soft capsules taken orally on an empty stomach or after meals in Chinese healthy adult volunteers

主要试验目的：在健康男性受试者体内，分别在空腹和餐后条件下，以Astellas Pharma Europe B.V.持有的恩扎卢胺软胶囊（商品名：安可坦®；规格：40 mg）为参比制剂，研究山西振东制药股份有限公司研制的恩扎卢胺软胶囊（规格：40 mg；受试制剂）的药代动力学，评价受试制剂与参比制剂是否具有生物等效性。次要试验目的：观察受试制剂、参比制剂在健康男性受试者中的安全性。次要试验目的：观察受试制剂、参比制剂在健康男性受试者中的安全性。

[Translation]

The main purpose of the study is to study the pharmacokinetics of enzalutamide soft capsules (specification: 40 mg; test preparation) developed by Shanxi Zhendong Pharmaceutical Co., Ltd. in healthy male subjects under fasting and postprandial conditions, using enzalutamide soft capsules (trade name: Ancotan®; specification: 40 mg) owned by Astellas Pharma Europe B.V. as the reference preparation, and to evaluate whether the test preparation and the reference preparation are bioequivalent. Secondary purpose of the study: to observe the safety of the test preparation and the reference preparation in healthy male subjects. Secondary purpose of the study: to observe the safety of the test preparation and the reference preparation in healthy male subjects.

Start Date21 Feb 2023

Sponsor / Collaborator

Shanxi Zhendong Pharmaceutical Co., Ltd.

CTR20221983

/ CompletedNot Applicable

空腹及餐后口服马来酸曲美布汀片在中国成年健康志愿者中的人体生物等效性研究

[Translation] Study on the bioequivalence of fasting and fed oral trimebutine maleate tablets in Chinese healthy adult volunteers

在健康受试者体内，分别在空腹和餐后条件下，以田边三菱制药株式会社持有的马来酸曲美布汀片（商品名：Cerekinon®；规格：100 mg）为参比制剂，研究山西振东安欣生物制药有限公司研制的马来酸曲美布汀片（规格：100 mg；受试制剂）的药代动力学，评价受试制剂与参比制剂是否具有生物等效性。次要试验目的：观察健康受试者口服受试制剂、参比制剂的安全性。

[Translation]

In healthy subjects, the pharmacokinetics of trimebutine maleate tablets (specification: 100 mg; test preparation) developed by Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. were studied under fasting and postprandial conditions, using trimebutine maleate tablets (trade name: Cerekinon®; specification: 100 mg) owned by Mitsubishi Tanabe Pharma Corporation as the reference preparation, and the bioequivalence of the test preparation and the reference preparation was evaluated. Secondary study objective: To observe the safety of oral administration of the test preparation and the reference preparation in healthy subjects.

Start Date04 Aug 2022

Sponsor / Collaborator

Shanxi Ante Bio-Pharmaceutical Co., Ltd.

100 Clinical Results associated with Shanxi Zhendong Pharmaceutical Co., Ltd.

0 Patents (Medical) associated with Shanxi Zhendong Pharmaceutical Co., Ltd.

Literatures (Medical) associated with Shanxi Zhendong Pharmaceutical Co., Ltd.

01 Mar 2025·Food Chemistry

Metabolomics analysis of Astragali Radix in Shanxi Province: Investigating the impact of various cultivation methods and growth years on metabolite profiles

Article

Author: Liu, Yuetao ; Li, Aiping ; Qin, Xuemei ; Hou, Jinli ; Wang, Guohong

Astragali radix (HQ) is a herb with rich medicinal and edible value. Wild-simulated HQ (FYS) and Transplanted HQ (PZ) are its currently two primary forms available in the market. Metabolomics was employed to investigate their intricate metabolic variations under various cultivation methods and growth years. Notable similarities were observed in their metabolic changes across various growth years. Specifically, saponins was higher in the early growth phase, while flavonoids increased in the later. Additionally, comparative analysis of HQ samples from different cultivation methods indicated that FYS generally exhibited different chemical characteristics compared to PZ within the same market circulation period, and Calycosin-7-O-Glc-6"-O-acetate and Cycloastragenol-H₂O might be used to discriminant them (the content of Calycosin-7-O-Glc-6"-O-acetate and Cycloastragenol-H₂O was higher in FYS than in PZ). This approach elucidates the dynamic change pattern of characteristic metabolites and pinpoints potential biomarkers for both FYS and PZ, thereby enhancing our understanding of these medicinal materials.

01 Feb 2024·Bioorganic Chemistry

Fourteen new 2-benzylbenzofuran glycosides with cardioprotective activity from Heterosmilax yunnanensis

Article

Author: Zhang, Xiao-Wei ; Yuan, Xiang ; Lu, Kai-Zhou ; Yang, Ya-Nan ; Du, Rong-Rong ; Qin, Wen-Jie ; Li, Kun ; Duan, Xiu-Mei ; Zhou, Ji-Chao ; Zhang, Pei-Cheng

Fourteen new 2-benzylbenzofuran O-glycosides (1-13, 15) and one new key precursor, diarylacetone (14) were isolated from the roots of Heterosmilax yunnanensis Gagnep, which all have characteristic 2,3,4-O-trisubstituted benzyl. Their structures were elucidated by 1D and 2D NMR, HRESIMS, UV and IR. The isolated compounds were assessed for their cardioprotective activities and compounds 1, 3 and 6 could significantly improve cardiomyocytes viability. Moreover, the mechanistic study revealed that these three compounds could significantly decrease intracellular ROS levels and maintain mitochondrial homeostasis upon hypoxia inducement. Consequently, 1, 3 and 6 might serve as potential lead compounds to prevent myocardial ischemia.

01 Feb 2024·Talanta

A unique phenothiazine-based fluorescent probe using benzothiazolium as a reactivity regulator for the specific detection of hypochlorite in drinking water and living organisms

Article

Author: Fang, Jie ; Li, Wei ; Seidu, Mohammed Awal ; Li, Xiang ; Gao, Shihao ; Gao, Chao ; Zhou, Hongjun

As a common disinfectant and an essential reactive oxygen species (ROS), hypochlorite (ClO^-) plays vital roles in both water treatment and cell metabolism, but its abnormal level can cause serious harm to human health. Therefore, quantifying ClO^- level in drinking water and living organisms is extremely significant. Herein, we decorated different cationic heterocycles on phenothiazine core to construct three fluorescent probes for ClO^-. According to the results, only benzothiazolium moiety reasonably adjusted the electron cloud density at sulfur atom of phenothiazine core for the specific oxidation with ClO^-, thus endowing the prepared probe PT-BT with a perfect selectivity for ClO^-. Meanwhile, PT-BT exhibited a low detection limit (38 nM) and a fast response (within 20 s) toward ClO^-. Furthermore, this probe was utilized to fabricate a ready-to-use test strip, which could quantitatively measure ClO^- level in real water samples by a portable smartphone sensing platform. Notably, PT-BT targeted mitochondria efficiently, and successfully visualized endogenous ClO^- in living cells and zebrafish larvae. Especially, PT-BT was able to monitor the dynamic change of ClO^- level in inflammatory mice. These results strongly manifested that probe PT-BT was a promising tool for detecting ClO^- in drinking water and living organisms.

100 Deals associated with Shanxi Zhendong Pharmaceutical Co., Ltd.

100 Translational Medicine associated with Shanxi Zhendong Pharmaceutical Co., Ltd.

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 30 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

IND Application

IND Approval

Phase 1 Clinical

Phase 2 Clinical

Approved

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

FuFangKuShen	Cancer Pain More	Approved
Leucovorin Calcium	Anemia More	Approved
Amoxicillin/Flucloxacillin Magnesium	Infection of digestive system More	Approved
Changrui Enema Powder	Radiation proctitis More	Phase 2
Larotaxel Dihydrate ( Tubulin )	Advanced Malignant Solid Neoplasm More	Phase 1

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis